A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
City of Hope Medical Center
Stanford University
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Scripps Health
University of California, Davis